Elevance Health (ELV) revenue
Elevance Health (ELV) reported revenue of $199.13B in fiscal 2025 (the year ended December 31, 2025). That is 12.6% higher than the $176.81B of fiscal 2024. Figures as of 18 Nov 2026, 09:35 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Revenue, fiscal 2025
- $199.13B
- Change on fiscal 2024
- +12.6%
- Growth, 5 years
- +10.3% a year
- Growth, 10 years
- +9.7% a year
- Highest on record
- $199.13Bfiscal 2025
- Lowest on record
- $58.70Bfiscal 2010
- Fiscal years on record
- 192007–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Elevance Health revenue, in more detail
Over the five fiscal years to 2025 revenue grew at a compound 10.3% a year; over ten years the rate was 9.7% a year. Across the 19 fiscal years on record (2007–2025), the highest was $199.13B in fiscal 2025 and the lowest $58.70B in fiscal 2010.
Revenue by fiscal year
Elevance Health revenue, year by year
| Fiscal year | Revenue | Change | Year ended |
|---|---|---|---|
| 2025 | $199.13B | 12.6% up | |
| 2024 | $176.81B | 3.2% up | |
| 2023 | $171.34B | 9.4% up | |
| 2022 | $156.60B | 13.0% up | |
| 2021 | $138.64B | 13.8% up | |
| 2020 | $121.87B | 16.9% up | |
| 2019 | $104.21B | 13.1% up | |
| 2018 | $92.11B | 2.3% up | |
| 2017 | $90.04B | 6.1% up | |
| 2016 | $84.86B | 7.2% up | |
| 2015 | $79.16B | 7.2% up | |
| 2014 | $73.87B | 4.0% up | |
| 2013 | $71.02B | 15.5% up | |
| 2012 | $61.50B | 1.3% up | |
| 2011 | $60.71B | 3.4% up | |
| 2010 | $58.70B | 9.6% down | |
| 2009 | $64.94B | 6.0% up | |
| 2008 | $61.25B | 0.1% up | |
| 2007 | $61.17B | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.
How to read it
Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.
Revenue at health care companies of similar size
| Company | Revenue | Fiscal year |
|---|---|---|
| CVS Health CVS | $402.07B | 2025 |
| HCA Healthcare HCA | $75.60B | 2025 |
| GSK GSK | £32.67B | 2025 |
| Regeneron Pharmaceuticals REGN | $14.34B | 2025 |
| Elevance Health ELV | $199.13B | 2025 |
| Cigna Group CI | $273.85B | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Elevance Health, figure by figure
- Elevance Health market cap
- Elevance Health earnings
- Elevance Health earnings per share (EPS)
- Elevance Health P/E ratio
- Elevance Health P/S ratio
- Elevance Health P/B ratio
- Elevance Health free cash flow
- Elevance Health operating margin
- Elevance Health dividend
- Elevance Health shares outstanding
- Elevance Health total debt
- Elevance Health cash on hand
- Elevance Health total assets
- Elevance Health return on equity (ROE)
- Elevance Health return on invested capital (ROIC)
Elevance Health (ELV) overview: price, valuation and scorecardAll health care companies by market value
Elevance Health revenue: questions and answers
What is Elevance Health's revenue?
Elevance Health (ELV) reported revenue of $199.13B in fiscal 2025 (the year ended December 31, 2025). That is 12.6% higher than the $176.81B of fiscal 2024.
What is the growth rate of Elevance Health's revenue?
Over the five fiscal years to 2025 revenue grew at a compound 10.3% a year; over ten years the rate was 9.7% a year.
What are the highest and lowest revenue figures on record for Elevance Health?
Across the 19 fiscal years on record (2007–2025), the highest was $199.13B in fiscal 2025 and the lowest $58.70B in fiscal 2010.
How is Elevance Health's revenue calculated?
Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Elevance Health it is on record here for 19 fiscal years, 2007 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: revenue
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Elevance Health (ELV) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/ELV/revenue
Underlying data: the company's filings with the SEC and Yahoo Finance.